Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3123 results found
Expand All
Apply All
3123 results found

Good Day BIO: WHO's global framework for regulating human genome editing
Share
Good Day BIO Newsletter  •  July 26, 2021
Starting the last week of July with a look at a recent report on human genome editing from the WHO's Expert Committee, as well as what we know about how to combat vaccine hesitancy. (762 words, 3 minutes, 48 seconds)
Read More

Good Day BIO: How we can end African swine fever
Share
Good Day BIO Newsletter  •  July 23, 2021
ICYMI: African swine fever is making a comeback in Germany—this time in farm pigs. We explain how we could end this disease, as well as recap what BIO’s Dr. Michelle said during a Washington Post event about health equity. (770 words, 3 minutes, 51 seconds)
Read More

BIO Promotes Sarah Gallo to Vice President, Agriculture and Environment
Share
Press Release  •  July 22, 2021
The Biotechnology Innovation Organization (BIO) is pleased to announce today the promotion of Sarah Gallo to Vice President, Agriculture and Environment. In her new role, Sarah will lead the policy and market access strategies for BIO’s Agriculture and Environment Section, which is comprised of members from the former Food and Agriculture and Industrial and Environmental Sections. In this role, Sarah will also serve as the primary liaison between the organization and the section board of directors. “I could not be more thrilled to welcome Sarah to BIO’s leadership team,” said BIO’s President and CEO Dr. Michelle McMurry-Heath. “Throughout BIO’s restructure, Sarah’s leadership has been instrumental in uniting our agriculture and environment companies and distilling their priorities into BIO’s mission. These companies are creating breakthroughs that will be essential to the future of our society, and I look forward to watching BIO’s Agriculture and Environment Section grow under her leadership.” Sarah joined BIO in 2018 to lead market access strategy for BIO’s food and agriculture members. During that time, Sarah worked closely with BIO’s companies to spearhead initiatives on transparency and public awareness. “I am excited to be taking on this challenge during a transformational time at BIO,” said Sarah Gallo. “Our members are creating some of the most compelling breakthroughs of our generation, which will help to address global challenges like climate change and access to nutritious, healthy food. I want to thank Dr. Michelle and BIO’s leadership for the opportunity to lead this section and look forward to continuing to work closely with our members to showcase the many benefits of biotechnology across agriculture and the environment.” Prior to joining BIO, Gallo worked in government affairs and public policy for CHS, Inc. and the National Corn Growers Association. She also served as the Agriculture Counsel for the U.S. House of…
Read More

BIO Comments on Cures 2.0 Discussion Draft
Share
Human Health  •  Letters, Testimony & Comments  •  July 22, 2021
The Biotechnology Innovation Organization (BIO) is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. Our mission is to advance biotechnology innovation by promoting sound public policy and fostering collaboration, both locally and globally. Our members range from entrepreneurial companies developing a first product to Fortune 500 multinationals. BIO and our members appreciate the opportunity to provide comments to the 21st Century Cures 2.0 proposal discussion draft.
Read More

Good Day BIO: COVAX Marketplace will boost global vaccine production
Share
Good Day BIO Newsletter  •  July 22, 2021
Lots of newness today: the new COVAX Marketplace, BIO’s new VP for Agriculture and Environment, and more news from Washington. (888 words, 4 minutes, 26 seconds)
Read More

BIO Comments on International Council for Harmonisation Q12: Implementation Considerations for FDA-Regulated Products
Share
Letters, Testimony & Comments  •  July 21, 2021
BIO appreciates FDA’s commitment to harmonization of regulatory concepts across regional Health Authorities through the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). Harmonization of critical regulatory concepts is an important part of ensuring a consistent and predictable regulatory environment and gives sponsors confidence that their drug development program will be generally accepted within different regions. BIO believes that the concepts in Q12 are important and warrant broad recognition across the globe. Even though implementation of Q12 is voluntary, this Draft Guidance explains FDA’s expectations on implementation of Q12 (e.g., format, eCTD locations for information) if an applicant so chooses to implement Q12 and thus is a helpful document. In BIO's comments, we requested additional clarity on how the Q12 draft guidance should be utilized by industry in conjunction with previously issued FDA guidances. We also noted the importance of globally aligned requirements for Established Conditions (ECs) and urged the Agency to carefully consider the terminology used throughout the draft guidance. Furthermore, we expressed concern about the potential introduction of new terms which are not internationally aligned. In line with this overarching feedback, a number of specific redline edits were provided.
Read More

Good Day BIO: “COVID-19 won’t just go away.”
Share
Good Day BIO Newsletter  •  July 21, 2021
Today, we have a quick recap of yesterday’s Senate hearing on the federal COVID-19 response, plus a look at a must-read long-read on how the tide is turning on GMOs and why it matters. (842 words, 4 minutes, 12 seconds)
Read More

BIO Signs on to Letter in Support of Under Secretary for Farm Production and Conservation Robert Bonnie
Share
Agriculture & Environment  •  Letters, Testimony & Comments  •  July 20, 2021
We write to express our support for the nomination of Robert Bonnie to serve as the U.S. Department of Agriculture’s Under Secretary for Farm Production and Conservation. The Under Secretary position is critical in overseeing the administration of a wide variety of USDA farm and conservation programs that directly serve farmers, ranchers, foresters, and landowners. Bonnie’s prior experiences show he is dedicated to serving U.S. agricultural producers, and improving the lands Americans depend on for food, fiber, water, recreation, and environmental enhancement. These experiences and his deep background knowledge make Bonnie uniquely qualified to serve as the USDA’s next Under Secretary for Farm Production and Conservation.
Read More

Good Day BIO: Cancer deaths are down—but inequity remains
Share
Good Day BIO Newsletter  •  July 20, 2021
Today, we look at a recent report that has both good and bad news on cancer deaths in the U.S., as well as how gene editing can make biryani ingredients more sustainable and resilient. (772 words, 3 minutes, 51 seconds)
Read More

Good Day BIO: "A pandemic of the unvaccinated"
Share
Good Day BIO Newsletter  •  July 19, 2021
We start a new week bearing bad news: COVID cases are rising across the U.S., and extreme climate events are increasing around the world. Fortunately, biotech can deliver solutions to both challenges—but we have some work to do to get them where they need to go. (766 words, 3 minutes, 49 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 174
  • 175
  • 176
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO